You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盛業(06069.HK)中標國藥樂仁堂旗下5個醫院智能供應鏈管理項目
盛業(06069.HK)公布,其間接全資附屬盛業信息科技(深圳)成功中標國藥樂仁堂旗下3家附屬的5個醫院智能供應鏈管理「SPD」解決方案採購項目,估計合約總值約3,900萬元人民幣。 根據中標內容,集團將提供智能硬件、配套軟件、解決方案設計以及系統集成支持,為相關醫院的醫療物資供應、加工與配送等物流過程進行數碼化、智能化集中管理。 國藥樂仁堂由中國醫藥集團旗下國藥控股(01099.HK)與樂仁堂投資集團共同投資組建的大型醫藥商業企業。國藥樂仁堂銷售網絡覆蓋河北省內全部的三甲和二甲醫院,95%的縣級醫療機構以及80%的藥店、社區門診和鄉鎮衛生院等1.6萬餘家終端客戶,是醫藥流通領域的龍頭企業。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account